Format

Send to

Choose Destination
J Med Chem. 1997 Oct 10;40(21):3319-22.

C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in mice.

Author information

1
Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, Michigan 48105, USA. mcnamad@aa.wl.com
PMID:
9341905
DOI:
10.1021/jm970470c
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center